Our Latest News and Events

Read about our latest news and events.
Contact us directly for any media enquiries:
enquiries@pneumowave.com

January 12, 2023

PneumoWave raises £7.5 million Series A to accelerate clinical validation and regulatory submission of respiratory change diagnosis and monitoring platform

£5.2 m equity from Scottish National Investment Bank alongside £2.3 m from existing investors Scottish Enterprise, IIG, London & Scottish...

9 Min

August 30, 2022

Today is Opioid Awareness Day

Today is Opioid Awareness Day. Our Chief Executive Officer and Founder Dr Bruce Henderson has written a powerful opinion piece...

3 Min

June 20, 2022

PneumoWave Featured in the Scotsman

We are delighted to be featured in the Scotsman newspaper: Digital health firm PneumoWave aiming to double workforce on back...

1 Min

April 20, 2022

Dr Gary Cooney appointed as Mental Health Lead

PUBLISHED: APRIL 19, 2022 Digital health company PneumoWave today announced the appointment of Dr Gary Cooney as Mental Health Lead,...

2 Min

March 1, 2022

Dundee University start RESCU trial of PneumoWave’s wearable biosensor device aiming to cut opioid overdose deaths

Glasgow, February 28, 2022, Healthtech company PneumoWave today announced that Dundee University is commencing the clinical trial of its wearable...

6 Min

January 19, 2022

PneumoWave & King’s College London Collaborate in Clinical Trial

Wednesday 19th January Digital therapeutics company PneumoWave (formerly known as Altair Medical) announced today the use of their monitoring platform...

8 Min

November 2, 2021

PneumoWave and NHS Greater Glasgow & Clyde Announce Clinical Trial Aiming to Reduce Deaths from Respiratory Depression

Tuesday 2nd November Digital therapeutics company PneumoWave (formerly known as Altair Medical) announced today the commencement of a second clinical...

4 Min

October 13, 2021

Rebrand of Altair Medical to PneumoWave

Wednesday 13th October UK based Altair Medical today announced, as part of its ongoing growth story, that it is rebranding...

3 Min

April 16, 2021

Altair Medical secures $3.1m in Pre-Series A financing

Friday 16th April UK based Altair Medical today announced it has secured £2.25m ($3.1m) of Pre-Series A funding to further...

5 Min

February 9, 2021

Storm ID, Altair Medical & NHS GGC develop a respiratory monitoring service for COVID-19 patients in new clinical trial

Tuesday 9th February Scottish digital transformation consultancy Storm ID and Altair Medical have developed a new digital solution to help...

4 Min

October 20, 2020

Altair Medical accelerates development schedule by adopting FDA cleared cloud data management platform

Wednesday 20th October Altair Medical, (“Altair”) aims to revolutionize care for respiratory symptoms and diseases with its advanced, remote respiratory monitoring...

2 Min

February 24, 2020

Altair medical achieves FDA breakthrough status

Monday 24th February Altair Medical, a medical technology company developing a groundbreaking solution to the global opioid crisis, today announce that...

3 Min